The FDA's Schedule I label on cannabis is the single biggest barrier holding medical marijuana stocks back.
That barrier could be coming...
Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.
And there's...
By 2025, the biotech industry will be worth will be $727 billion - a 120% increase over its total value in 2015.
To help you take...
Since hitting a high in late January, the iShares Nasdaq Biotechnology ETF has slumped more than 11%. But that doesn't mean investors should stop...
Biotech stocks have been getting hit hard in early 2018, but it's largely because of market overreactions to minor setbacks and...
Our latest round of stocks to buy now is heavy on tech.
These stocks capitalize on legal marijuana, tailwinds in the biotech industry, a...
Another possible deal between two of the world's top pharmaceutical companies was announced this week when Shire Plc. (Nasdaq: SHPG) made an...
